How We Evaluated
Disclosure: Gene Matrix publishes this comparison and includes itself. That is a conflict — so we mitigated it the only honest way: one published scoring rubric applied identically to every brand, dated competitor claims, and explicit recommendations of competitors where they win.
Lab Grade
CLIA certification is the federal standard for clinical labs. It decides whether your results can be used for medical decisions, insurance reimbursement, and specialist referrals.
Genes Analyzed
Depth beats marketing breadth. A 108-gene sequencing panel catches hereditary risks a 3-variant chip test structurally cannot.
Medication Coverage
Pharmacogenomics is the most immediately actionable category in consumer genetics — how many drugs, and are CPIC/DPWG guidelines followed?
Price & Transparency
Published prices you can verify before buying — not quotes, not insurance gambles, not report-paywalls.
Counseling Access
A positive result needs a professional interpretation and a plan. Is a genetic counselor included or an upsell?
Turnaround
Days from sample to answers. When the answer changes your medication or screening plan, speed matters.
The 2026 Scorecard
[ Facts As Of August 2026 ]| Criterion | Gene Matrix | 23andMe | SelfDecode | Color | tellmeGen |
|---|---|---|---|---|---|
| Lab Grade | CLIA-certified, CAP-accredited clinical lab (CLIA ID 14D2276402) | Consumer-grade; health reports labeled not for medical use | Analysis platform; relies on chip genotyping and imputation | CLIA-certified, CAP-accredited | Chip-based consumer testing; wellness-oriented |
| Genes Analyzed | 108 cancer genes; 230+ PGx genes; 130+ in comprehensive panel | 3 BRCA variants (Ashkenazi-focused); limited health variants | Large SNP dataset via chip + imputation; report-driven | 30-gene hereditary cancer panel | Broad SNP-chip health & trait reports |
| Medications (PGx) | 700+ medications, CPIC/DPWG-aligned, incl. psychiatric | Minimal — a small set of drug-gene reports | 50+ medications in PGx reports | Limited — 14-gene PGx offering | Some drug-response traits in wellness reports |
| Price & Transparency | Published: $249–$599/test or all 11 at $89/mo ($712/yr annual); HSA/FSA | Published: ~$99–$229 one-time; membership add-ons | Published subscriptions; report-heavy upsell model | Historically $249–$799; often employer-subsidized | Published: budget-tier one-time pricing |
| Counseling Access | Board-certified counselor included with every positive result | Not included | Not included — DIY interpretation | Included with high-risk results in most programs | Not included |
| Turnaround | 5–7 days from lab receipt; 48-hour priority processing for members | 3–5 weeks | Varies; instant if uploading existing raw data | Several weeks | 4–6 weeks typical for chip processing |
| Result Updates | Quarterly AI reinterpretation included with membership | Static from test date | Subscription report updates | Static from test date | Static from test date |
23andMe®, SelfDecode™, Color®, and tellmeGen™ are trademarks of their respective owners. Independent comparison under nominative fair use — no affiliation or endorsement implied. Competitor details verified August 2026; offerings change — confirm on each company’s site.
Verdicts by Use Case
[ When Each Wins — Honestly ]
Ancestry & family history curiosity → 23andMe. Self-directed health-data exploration with existing raw data → SelfDecode. Employer-sponsored hereditary cancer screening → Color. Broad wellness traits on a tight budget → tellmeGen. Clinical-grade answers you can take to a doctor — hereditary cancer, medication response, mental-health genetics — with counseling included and results in days → Gene Matrix. The right test is the one whose lab grade matches the decision you’re making.
Roundup FAQs
It depends on your goal. For ancestry and casual traits, 23andMe remains the category default. For self-directed health data exploration, SelfDecode offers deep reporting. For employer-sponsored cancer screening, Color works well. For clinical-grade answers — hereditary cancer, medication response, mental health genetics — with a physician-ready report and counseling included, Gene Matrix is the strongest option. tellmeGen is a budget chip-based alternative for broad wellness traits.
We wrote it and we include ourselves — that is disclosed at the top of the page. To stay honest, we score every option (including ourselves) on the same six published criteria, date every competitor claim as of 2026, and tell you explicitly when a competitor is the better choice for a use case — for example, 23andMe for ancestry. Verify anything here against each company’s current site.
Six things: lab grade (CLIA certification determines whether results are medically usable), genes analyzed (depth beats breadth of marketing), medication coverage (PGx is the most actionable category), price transparency (published prices vs quotes), counseling access (a result without interpretation is just a PDF), and turnaround time. Score any test on those six and the marketing noise falls away.
Cheap tests are usually accurate at what they measure — the issue is how little they measure. SNP-chip tests read a preselected set of variants and label results not for medical use. Clinical-grade labs use next-generation sequencing with validated assays; Gene Matrix achieves up to 99.9% analytical accuracy in a CLIA-certified lab. If you need a medical answer, lab grade matters more than price.